According to ChainCatcher, information from Titan Partners Group and the crypto investment company GSR indicates that the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing a dedicated Litecoin treasury strategy. Currently, over $100 million in funds have been committed to this project.
It is worth noting that Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors. Additionally, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy is highly aligned with the foundation's core mission of promoting global Litecoin adoption.

